| Tackling neuroinflammation and cholinergic deficit in Alzheimer's disease: multi-target inhibitors of cholinesterases, cyclooxygenase-2 and 15-lipoxygenase ED AlFadly, PA Elzahhar, A Tramarin, S Elkazaz, H Shaltout, ... European journal of medicinal chemistry 167, 161-186, 2019 | 95 | 2019 |
| Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease R Rafeh, A Viveiros, GY Oudit, AF El-Yazbi Clinical Science 134 (7), 827-851, 2020 | 57 | 2020 |
| Amelioration of perivascular adipose inflammation reverses vascular dysfunction in a model of nonobese prediabetic metabolic challenge: potential role of antidiabetic drugs MAW Elkhatib, A Mroueh, RW Rafeh, F Sleiman, H Fouad, EI Saad, ... Translational Research 214, 121-143, 2019 | 38 | 2019 |
| Phosphorus supplementation mitigates perivascular adipose inflammation–induced cardiovascular consequences in early metabolic impairment HS Dwaib, G Ajouz, I AlZaim, R Rafeh, A Mroueh, N Mougharbil, ME Ragi, ... Journal of the American Heart Association 10 (24), e023227, 2021 | 16 | 2021 |
| Translational aspects of the mammalian target of rapamycin complexes in diabetic nephropathy A Abou Daher, S Alkhansa, WS Azar, R Rafeh, HE Ghadieh, AA Eid Antioxidants & Redox Signaling 37 (10-12), 802-819, 2022 | 6 | 2022 |
| The perivascular Adipocyte: A Crooked Middleman In The Translation Of Metabolic challenge Into Early Vascular Dysfunction RW Rafeh | | 2021 |
| Antimicrobial Therapeutic Drug Monitoring RW Rafeh, K Abdelraouf, N Haddad, N Rizk, AF El-Yazbi 21st Century Challenges in Antimicrobial Therapy and Stewardship 3, 263, 2020 | | 2020 |
| Perivascular adipose inflammation underlies early vascular dysfunction in the course of metabolic deterioration M Elkhatib, A Mroueh, R Rafeh, F Sleiman, A El-Yazbi BRITISH JOURNAL OF PHARMACOLOGY 177 (11), 2608-2609, 2020 | | 2020 |
| A Possible Role of Perivascular Adipocyte Stress in Cardiovascular Dysfunction Prior to the Onset of Diabetes RW Rafeh, A Mroueh, A Eid, AF El‐Yazbi The FASEB Journal 33 (S1), 512.10-512.10, 2019 | | 2019 |
| Amelioration of perivascular adipose inflammation reverses vascular dysfunction in a model of nonobese prediabetic metabolic challenge: potential role of antidiabetic drugs A Mroueh, RW Rafeh, F Sleiman, H Fouad, EI Saad, O Elgaddar, K Issa, ... Elsevier Inc., 2019 | | 2019 |
